Close Menu

Blogger Keith Robison has been shopping about for a new programming language. Choosing between Python and C#, he is going with C#. The language itself is strong and consistent, the .NET libraries cover a lot, and, Visual Studio is a "very slick integrated development environment," he writes. There is, Robison adds, a downside from a bioinformatics point of view, he is "not going with the crowd."

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

According to BBC News, the global vaccine-sharing initiative has sent its first shipment, which arrived in Ghana this week.

CNN reports that a US Food and Drug Administration document says Johnson & Johnson's SARS-CoV-2 vaccine meets the requirements to receive an Emergency Use Authorization.

Researchers in France are developing a new, fast test for SARS-CoV-2 that initial testing indicates may be highly accurate, the Guardian says.

In Cell this week: analysis of fitness patterns among SARS-CoV-2 isolates, single-cell transcriptome analysis of immune features in COVID-19, and more.